Form D · Biotechnology
Benten BioServices, Inc.
Malvern, PA · CIK 0001538610
Offering snapshot reported May 15, 2013 · SEC filing
- Reported sold
- $78.5K Offering amount: $250K
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Apr 30, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 15, 2013 | Initial | $78,500 | No comparison | 6 | SEC filing |
| Feb 1, 2013 | Amendment | $1,315,000 | $40,000vs Jan 4, 2012 | 5 | SEC filing |
| Oct 4, 2012 | Initial | $1,100,000 | No comparison | 3 | SEC filing |
| Aug 22, 2012 | Initial | $2,944,323 | No comparison | 19 | SEC filing |
| Jul 18, 2012 | Amendment | $2,739,500 | $1,464,500vs Jan 4, 2012 | 17 | SEC filing |
| Jan 4, 2012 | Initial | $1,275,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-196528
Source: Form D, filed May 15, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Warren Chaunce Bogard | Director |
| Kevin Harter | Director |
| Paula Z. Mac Donald | Director, Executive |
| David Mc Lachlan | Director |
| Thomas Penn | Director |
| Bernard Rudnick | Director |
| Michele Washko | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
347 Phoenixville Pike
Malvern, PA, 19355
Malvern, PA, 19355